Literature DB >> 11803210

The influence of smoking and parity on serum markers for Down's syndrome screening.

Dubravka Tislarić1, Bojana Brajenović-Milić, Smiljana Ristić, Visnja Latin, Marta Zuvić-Butorac, Josip Bacić, Marijan Petek, Miljenko Kapović.   

Abstract

OBJECTIVE: To evaluate the impact of smoking and number of previous births on maternal serum levels of alpha-fetoprotein and free beta-subunit of human chorionic gonadotropin (free beta-hCG).
METHODS: The study included 3,252 completed unaffected singleton pregnancies that proceeded beyond 37 weeks' gestation and resulted with a birth of healthy child. Smoking status of mothers and data concerning gravidity and parity were collected at the sampling date. Serum markers were measured between 13 and 22 gestational weeks, corrected for maternal weight, and converted to multiples of median (MoM) for unaffected pregnancy of the corresponding gestational age. Median MoM values for both markers were examined in relation to both: smoking habits and number of previous births.
RESULTS: Smokers had significantly decreased free beta-hCG MoM values compared to nonsmokers (p < 0.001). The median levels showed a negative relationship with the number of previous births. The significance of a decreasing trend was proved, both in smokers (p < 0.001) and nonsmokers (p < 0.001). The median maternal serum alpha-fetoprotein MoM values did not show any significant dependence, neither with regard to smoking (p = 0.65) nor with regard to parity (p = 0.07).
CONCLUSIONS: The recommendable adjustment of serum markers to smoking habits, especially concerning the free beta-hCG levels, would be worthwhile. The evidence of the coexisting influence of parity on serum levels of free beta-hCG, both in smokers and nonsmokers, should perhaps be a stimulus for reconsideration of which corrections the screening performance is dependent on. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11803210     DOI: 10.1159/000047999

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  10 in total

Review 1.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 2.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 3.  Second trimester serum tests for Down's Syndrome screening.

Authors:  S Kate Alldred; Jonathan J Deeks; Boliang Guo; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

4.  Free β-human chorionic gonadotropin, total human chorionic gonadotropin and maternal risk of breast cancer.

Authors:  Adetunji T Toriola; Egle Tolockiene; Helena Schock; Helja-Marja Surcel; Anne Zeleniuch-Jacquotte; Goran Wadell; Paolo Toniolo; Eva Lundin; Kjell Grankvist; Annekatrin Lukanova
Journal:  Future Oncol       Date:  2014-02       Impact factor: 3.404

5.  Maternal hormones during early pregnancy: a cross-sectional study.

Authors:  Tianhui Chen; Eva Lundin; Kjell Grankvist; Anne Zeleniuch-Jacquotte; Marianne Wulff; Yelena Afanasyeva; Helena Schock; Robert Johansson; Per Lenner; Goran Hallmans; Goran Wadell; Paolo Toniolo; Annekatrin Lukanova
Journal:  Cancer Causes Control       Date:  2010-01-19       Impact factor: 2.506

6.  Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy.

Authors:  James E Haddow; Monica R McClain; Geralyn Lambert-Messerlian; Glenn E Palomaki; Jacob A Canick; Jane Cleary-Goldman; Fergal D Malone; T Flint Porter; David A Nyberg; Peter Bernstein; Mary E D'Alton
Journal:  J Clin Endocrinol Metab       Date:  2008-06-10       Impact factor: 5.958

7.  Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study.

Authors:  Annekatrin Lukanova; Ritu Andersson; Marianne Wulff; Anne Zeleniuch-Jacquotte; Kjell Grankvist; Laure Dossus; Yelena Afanasyeva; Robert Johansson; Alan A Arslan; Per Lenner; Göran Wadell; Göran Hallmans; Paolo Toniolo; Eva Lundin
Journal:  Am J Epidemiol       Date:  2008-10-20       Impact factor: 4.897

8.  Reference ranges and determinants of total hCG levels during pregnancy: the Generation R Study.

Authors:  Tim I M Korevaar; Eric A P Steegers; Yolanda B de Rijke; Sarah Schalekamp-Timmermans; W Edward Visser; Albert Hofman; Vincent W V Jaddoe; Henning Tiemeier; Theo J Visser; Marco Medici; Robin P Peeters
Journal:  Eur J Epidemiol       Date:  2015-05-12       Impact factor: 8.082

Review 9.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30

Review 10.  Urine tests for Down's syndrome screening.

Authors:  S Kate Alldred; Boliang Guo; Yemisi Takwoingi; Mary Pennant; Susanna Wisniewski; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.